Skip to main content

Common Genetic Risk Seen for Primary Ovarian Insufficiency, Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on July 31, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, July 31, 2024 -- There seems to be a common genetic risk for primary ovarian insufficiency (POI) and reproductive cancer risk, according to a study published online July 12 in the Journal of Clinical Endocrinology & Metabolism.

Kristina Allen-Brady, Ph.D., M.P.H., from the Huntsman Cancer Institute at the University of Utah in Salt Lake City, and colleagues conducted a case-control population-based study using records from 1995 to 2022 to examine whether a subset of women with POI and their family members have an increased risk for cancer. The analyses included 613 women with POI and their relatives from two major Utah academic health care systems.

The researchers observed a significant increase in breast cancer among women with POI (odds ratio, 2.20) and a nominally significant increase in ovarian cancer. Probands with POI were aged 36.5 ± 4.3 years when diagnosed with POI and were aged 59.5 ± 12.7 years when diagnosed with cancer. Causal and candidate gene variants were identified for cancer and POI. An increased risk for breast and colon cancer (odds ratios, 1.28 and 1.50, respectively) was seen among second-degree relatives of these women. The risk for prostate cancer was increased in first-, second-, and third-degree relatives (odds ratios, 1.64, 1.54, and 1.33, respectively).

"Our data suggest that a subset of women with POI need counseling regarding future cancer risk," the authors write. "Recommendations will likely depend on underlying family history and genetic risk."

Several authors disclosed financial ties to Fabric Genomics.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Recommendations Updated on Diagnosis, Management of Premature/Primary Ovarian Insufficiency

MONDAY, Dec. 16, 2024 -- In an evidence-based guideline issued by the Centre for Research Excellence in Women's Health in Reproductive Life and published online Dec. 8 in...

Infertility Without Treatment Linked to Autoimmune Rheumatic Disease After Childbirth

TUESDAY, Dec. 10, 2024 -- For women who give birth, infertility without fertility treatment is associated with an increased risk for incident systemic autoimmune rheumatic disease...

Half of Young Cancer Patients Report Fertility Preservation Discussion With Provider

TUESDAY, Nov. 19, 2024 -- Many young patients with early-onset cancer report having a fertility preservation (FP) discussion with their health care professional prior to...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.